Inventing future therapies. Now.
THE BERLIN CENTER FOR GENE AND CELL THERAPIES IS WHERE START-UPS COME TO TRANSLATE GENE AND CELL THERAPY RESEARCH INTO A POSITIVE PATIENT IMPACT – THROUGH A DEDICATED INCUBATOR AND A PARTNER-OPERATED GMP MANUFACTURING UNIT.
The Berlin Center for Gene and Cell Therapies connects a start-up incubator operated by Gene and Cell Therapies Incubator Berlin GmbH with independently operated GMP manufacturing and consulting services – enabling start-ups to transform research into market-ready therapy through coordinated, but distinct, offerings.
For the benefit of patients.
Gene and cell therapies (GCTs) have the potential to transform the lives of patients and revolutionize the way we manage diseases and healthcare. They are highly innovative therapies that aim to prevent, stop, or reverse disease progression by addressing its root cause – and to make the treatment of presently untreatable diseases possible.
W H A T W E O F F E R
Going beyond. Together.
The Berlin Center for Gene and Cell Therapies, jointly initiated by Bayer and Charité, will be a unique hub within an inspiring biotech ecosystem. At its core is the Gene and Cell Therapies Incubator Berlin GmbH, operating the start-up incubator, alongside separately operated GMP manufacturing facilities, laboratories, and mentoring services – coordinated under the BC GCT umbrella from research to realization.
Mentoring and consulting services.
Knowledge increases by sharing. This can’t be more true than for our open network with experts and mentors for all relevant fields start-ups aiming to make a difference in GCT: from entrepreneurship and business development, to regulatory affairs, clinical development, and more.
Want to be a mentor?
Our innovators have groundbreaking visions, but they need the strategic guidance of experienced professionals to bring their ideas to life. If you have a proven track record and a desire to help teams successfully execute their strategies, we want to hear from you. Click the contact button to reach out and explore our mentoring opportunities.
The place for innovators.
The center is located in the heart of Berlin, as part of the Health Innovation Quarter Berlin‑Mitte (designated Future Site), just a ten-minute bike ride from Berlin central station and overlooking the waters of Nordhafen. Neighboring the Bayer campus it is located between two Charité campuses and close to the Berlin Institute of Health at Charité (BIH), surrounded by other world-renowned institutions like the Max Delbrück Center. Distances are short to the rich pool of skilled professionals and scientists, enabling the circulation and cross-fertilization of ideas.
Furthermore, co-located in the same building will be Bayer Co.Lab Berlin strengthening the biotech ecosystem.
Our partners.
The future has started.
Together with Germany’s Federal Chancellor Olaf Scholz and high-caliber government officials, Bayer and Charité publicly launched the Berlin Center for Gene and Cell Therapies in June 2024 – setting the start for this future powerhouse of GCT innovation.